ReviewPharmaceuticals (Basel, Switzerland)2021

TRK Inhibitors: Tissue-Agnostic Anti-Cancer Drugs.

Sun-Young HanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.